Literature DB >> 23459569

A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.

Aurélie Ruet1, Mathilde S A Deloire, Julie Charré-Morin, Delphine Hamel, Bruno Brochet.   

Abstract

BACKGROUND: Cognitive impairment in multiple sclerosis (MS) primarily applies to information processing speed (IPS).
OBJECTIVE: To evaluate psychometric properties of a new digit/symbol substitution test in healthy subjects and patients with MS, and assess its ability to detect IPS impairment in patients with MS.
METHODS: A sample of MS patients, 60 relapsing-remitting (RRMS) and 41 primary progressive MS (PPMS), and 415 healthy controls (HCs) underwent an IPS battery, including assessment of reaction times of subtests of the Test of Attentional Performance battery and a newly developed in-house digit/symbol substitution task, the Computerised Speed Cognitive Test (CSCT). The CSCT was additionally evaluated in a second cohort of 31 RRMS and 12 progressive MS patients, for comparison with the Symbol Digit Modalities Test (SDMT).
RESULTS: The CSCT had good reliability in both HCs and patients with MS. It showed a weak practice effect at the 6-month time point. This test had good ecological validity in MS patients. There was a strong correlation between the CSCT with the SDMT and with other IPS tests in patients with MS. The CSCT had the best sensitivity for predicting IPS impairment and was one of the most accurate tests among the IPS battery.
CONCLUSION: The CSCT appeared as a good candidate for detecting IPS impairment in MS patients.

Entities:  

Keywords:  Cognition; cognitive impairment; cognitive test; computerised neuropsychological test; information processing speed; multiple sclerosis; neuropsychological test; reaction times

Mesh:

Year:  2013        PMID: 23459569     DOI: 10.1177/1352458513480251

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  17 in total

1.  Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations.

Authors:  Charles Vecht; Alberto Duran-Peña; Caroline Houillier; Thomas Durand; Laurent Capelle; Gilles Huberfeld
Journal:  J Neurooncol       Date:  2017-05-10       Impact factor: 4.130

2.  Social cognition according to cognitive impairment in different clinical phenotypes of multiple sclerosis.

Authors:  Cecile Dulau; Mathilde Deloire; Helene Diaz; Aurore Saubusse; Julie Charre-Morin; Antoinette Prouteau; Bruno Brochet
Journal:  J Neurol       Date:  2017-02-20       Impact factor: 4.849

3.  A QTL on chromosome 3q23 influences processing speed in humans.

Authors:  Emma E M Knowles; Samuel R Mathias; Josephine Mollon; Amanda Rodrigue; Marinka M G Koenis; Thomas D Dyer; Harald H H Goring; Joanne E Curran; Rene L Olvera; Ravi Duggirala; Laura Almasy; John Blangero; David C Glahn
Journal:  Genes Brain Behav       Date:  2018-11-16       Impact factor: 3.449

4.  Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone.

Authors:  Andrew J Kwilasz; Laurel S Todd; Julissa C Duran-Malle; Anouk E W Schrama; Eric H Mitten; Tracey A Larson; Madison A Clements; Kevin M Harris; Scott T Litwiler; Xiaohui Wang; Anne-Marie Van Dam; Steven F Maier; Kenner C Rice; Linda R Watkins; Ruth M Barrientos
Journal:  Behav Brain Res       Date:  2020-09-06       Impact factor: 3.332

5.  Tablet-based screening improves continence management in multiple sclerosis.

Authors:  Heidi N Beadnall; Kushi E Kuppanda; Annmaree O'Connell; Todd A Hardy; Stephen W Reddel; Michael H Barnett
Journal:  Ann Clin Transl Neurol       Date:  2015-05-01       Impact factor: 4.511

6.  The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.

Authors:  Muriel Laffon; Grégoire Malandain; Heloise Joly; Mikael Cohen; Christine Lebrun
Journal:  Neurol Ther       Date:  2014-11-25

7.  Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.

Authors:  Athanasios Papathanasiou; Lambros Messinis; Vasileios L Georgiou; Panagiotis Papathanasopoulos
Journal:  ISRN Neurol       Date:  2014-03-13

8.  Cognitive function in idiopathic intracranial hypertension: a prospective case-control study.

Authors:  Hanne Maria Yri; Birgitte Fagerlund; Hysse Birgitte Forchhammer; Rigmor Højland Jensen
Journal:  BMJ Open       Date:  2014-04-08       Impact factor: 2.692

9.  EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients.

Authors:  Thomas Durand; Sophie Jacob; Laura Lebouil; Hassen Douzane; Philippe Lestaevel; Amithys Rahimian; Dimitri Psimaras; Loïc Feuvret; Delphine Leclercq; Bruno Brochet; Radia Tamarat; Fabien Milliat; Marc Benderitter; Nicolas Vayatis; Georges Noël; Khê Hoang-Xuan; Jean-Yves Delattre; Damien Ricard; Marie-Odile Bernier
Journal:  BMC Neurol       Date:  2015-12-18       Impact factor: 2.474

10.  Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life.

Authors:  Delphine Lamargue Hamel; Mathilde Deloire; Aurélie Ruet; Julie Charré-Morin; Aurore Saubusse; Jean-Christophe Ouallet; Bruno Brochet
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.